Long-Term Course of Korean Medicine Treatment for Lumbar Disc Herniation
Observational Study on the Long-Term Course of Integrative Korean Medicine Treatment for Lumbar Intervertebral Disc Herniation: Prospective Multicenter 10 Year Follow-up
1 other identifier
observational
65
1 country
1
Brief Summary
This observational study will assess the long-term course and effect of Korean medicine treatment in lumbar intervertebral disc herniation patients who received integrative Korean medicine treatment for 24 weeks as part of a previous clinical study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2018
CompletedFirst Posted
Study publicly available on registry
February 8, 2018
CompletedStudy Start
First participant enrolled
March 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2018
CompletedJune 4, 2018
June 1, 2018
2 months
February 1, 2018
June 1, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Visual Analogue Scale (VAS) of radiating leg pain
Visual Analogue Scale (VAS) uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain (minimum score: 0)' and 'worst pain imaginable (maximum score: 100)'. Total scores are recorded in millimeters with a total range of 0-100 millimeters. Higher VAS values represent more severe pain, and a greater change from baseline (If baseline - follow up is a positive value) indicates a better outcome.
Difference from baseline at 10 years
Secondary Outcomes (12)
Visual Analogue Scale (VAS) of low back pain
Baseline, and 10 years
Visual Analogue Scale (VAS) of radiating leg pain
Baseline, and 10 years
Numeric Rating Scale (NRS) of low back pain
Baseline, and 10 years
Numeric Rating Scale (NRS) of radiating leg pain
Baseline, and 10 years
Oswestry Disability Index (ODI)
Baseline, 10 years
- +7 more secondary outcomes
Study Arms (1)
Ten year follow-up group
No interventions will be administered (Magnetic Resonance Imaging (MRI) will be administered as an outcome measurement).
Interventions
Changes in size and severity of the main herniated disc causing radiating pain will be evaluated by radiology specialists and Korean medicine doctors (KMDs) and categorized into three groups (improved, worse or no discernible change) in comparison with the immediate previous MRI to track long-term changes and assess for correlations in subjective clinical symptoms and objective physical evaluation and MRI results.
Eligibility Criteria
Lumbar intervertebral disc herniation patients with a main complaint of radiating leg pain who received integrative Korean medicine treatment for 24 weeks at Jaseng Hospital of Korean Medicine (Gangnam main branch) as part of a previous clinical study which was conducted from November, 2006 to April, 2007.
You may qualify if:
- Lumbar intervertebral disc herniation patients with a main complaint of radiating leg pain who received integrative Korean medicine treatment for 24 weeks at Jaseng Hospital of Korean Medicine (Gangnam main branch) as part of a previous clinical study which was conducted from November, 2006 to April, 2007
- Patients who give voluntary written informed consent to long-term follow-up assessment (quantitative and qualitative questionnaires, and MRI) at 10 years.
You may not qualify if:
- Patients who cannot give voluntary written informed consent to this study or answer study questionnaires (e.g. severe psychological disorders)
- Patients participating in other clinical studies or otherwise deemed unsuitable by the researchers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jaseng Hospital of Korean Medicine
Seoul, 06110, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Me-riong Kim, KMD, M.Sc.
Jaseng Medical Foundation
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
February 1, 2018
First Posted
February 8, 2018
Study Start
March 10, 2018
Primary Completion
April 28, 2018
Study Completion
April 28, 2018
Last Updated
June 4, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share